Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Alteogen is a leading South Korean biopharmaceutical company dedicated to developing innovative biologics and novel therapies. Specializing in Antibody-Drug Conjugates (ADCs) and recombinant hyaluronidase technologies for subcutaneous drug delivery, Alteogen drives advancements through intensive research, development, and technology licensing. The company aims to create groundbreaking biopharmaceutical solutions for the global market, maximizing patient benefit.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Alteogen is scheduled to report its next quarterly earnings on 11/12/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Alteogen last reported quarterly earnings on 8/7/2026 (Q2 2026). Earnings per share (EPS) came in at 526.94 KRW.
Alteogen has beaten analyst EPS estimates in 1 of its last 3 evaluated quarters (beat rate: 33.3%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.